Aikaterini Panopoulou
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Early PET response predicts the risk of relapse after 2L axi-cel in large B-cell lymphoma.
Journal: Blood advances
Published: January 21, 2026
Early PET response predicts the risk of relapse after 2L axi-cel in large B-cell lymphoma.
Journal: Blood advances
Published: January 21, 2026
Outcomes of second-line axicabtagene ciloleucel for large B-cell lymphoma in the UK.
Journal: HemaSphere
Published: September 05, 2025
Risk factors for CAR T-cell manufacturing failure and patient outcomes in large B-cell lymphoma: a report from the UK National CAR T Panel.
Journal: Blood cancer journal
Published: August 21, 2024
CAR-T Cell Therapy for PTLD: Analysis of CAR-T Product, Engraftment, and Outcomes in Patients Receiving Parallel Immunosuppression.
Journal: EJHaem
Published: August 21, 2024
Axi-cel as a safe and effective treatment in older patients with large B-cell lymphoma.
Journal: Annals of palliative medicine
Published: October 14, 2023
Optimizing the value of lenalidomide maintenance by extended genetic profiling: an analysis of 556 patients in the Myeloma XI trial.
Journal: Blood
Published: September 06, 2022
Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma.
Journal: The Lancet. Haematology
Published: March 26, 2021
Mesothelioma and anti-Ma paraneoplastic syndrome; heterogeneity in immunogenic tumours increases.
Journal: Practical neurology
Published: June 11, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026